Home About Our Services Experience Publications News & Events Contact Us Downloads
OUR SERVICES

Health Economics

Patient-Reported Outcomes

Regulatory and Health Outcomes Strategy

Market Access

Health Preference Assessment

Pharmacoepidemiology and Risk Management

Drug Safety and Pharmacovigilance
> Pharmacovigilance Services
> Medical Monitoring
> Medical Writing
> Medical Consulting
> Training

Biometrics

Preclinical Pharmaceutical Sciences

Clinical and Medical Services

 

RTI-HS HomeOur ServicesDrug Safety and Pharmacovigilance › Medical Writing

Medical Writing

Regardless of your medical product study phase, our highly skilled medical writers can save you time and money by clearly and accurately writing the medical documents your development program requires. Our commitment to strong medical communication will provide you with thoughtful, cohesive medical documents that will stand up to regulatory and industry scrutiny. Below are examples of the various medical documents we routinely write:

Investigational Medical Product Applications
Investigational new drug (IND) submissions
Investigator’s brochures
Literature reviews and summaries
Standard operating procedures (SOPs)

New Drug Applications (NDAs)/Registration
Summary of clinical safety/ISS
Integrated summary of efficacy (ISE) reports
Clinical pharmacology
Non-clinical pharmacology and
toxicology
Benefit-risk analyses
120-day safety records
Clinical Development Phases I-III
Informed consents
Protocols
Annual safety reports
Clinical study reports
Regulatory reports
Serious adverse event (SAE) narratives

Post-Marketing
Periodic safety update reports (PSURs)
Periodic adverse drug experience reports (PADERs)
Manuscripts
SAE narratives
Regulatory reports

 


 
SENIOR LEADERSHIP

 
Maria Vazquez-Gragg, MD, MPM
Global Head, Safety and Pharmacovigilance


For a full list of scientific staff bios, click here.

 
DOWNLOADS

  Fact Sheets
- Pharmacovigilance
- Medical Monitoring
- Medical Consulting and
Writing
- Pharmacoepidemiology
- Therapeutic Risk Management

Other
FDA's Guidance for Industry:
- Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment

EMEA's Guidance
- Directive 2001/20/EC (Clinical Trial Directive of 4 April 2001)
- Pharmacovigilance for Medicinal Products for
Human Use


CONTACT US
To learn more about our research and consulting services, please call us at:
US: +1.800.262.3011
Spain: +34.93.241.7766
UK: +44(0)161.232.3400
Or email one of our experts directly.
Home | About | Our Services | Experience | Publications | News & Events | Contact Us | Downloads
©2008 RTI Health Solutions. All Rights Reserved.